Catalyst Wire Dossier Catalyst Wire Dossier

Verducatib

· Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Verducatib, covering 2026-04-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Test How Verducatib is Taken up in the Body of Healthy Chinese Participants [Phase 1]

See pricing